Cited by 377Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research

The DOI matches its Crossref record; 57 of the 62 references it cites were found in a registry or an index.

Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

Open access
Wilson, H L, Wong, A C C, Shaw, S R, Tse, W-Y, Stapleton, G A, Phelan, M C, Hu, S, Marshall, J, McDermid, H E·2003·Journal of Medical Genetics

Abstract

Methods : The 22q13 deletion syndrome (MIM 606232) is characterised by moderate to profound mental retardation, delay/absence of expressive speech, hypotonia, normal to accelerated growth, and mild dysmorphic features. We have determined the deletion size and parent of origin in 56 patients with this syndrome. Results: Similar to other terminal deletion syndromes, there was an overabundance of paternal deletions. The deletions vary widely in size, from 130 kb to over 9 Mb; however all 45 cases that could be specifically tested for the terminal region at the site of SHANK3 were deleted for this gene. The molecular structure of SHANK3 was further characterised. Comparison of clinical features to deletion size showed few correlations. Some measures of developmental assessment did correlate to deletion size; however, all patients showed some degree of mental retardation and severe delay or absence of expressive speech, regardless of deletion size. Conclusion : Our analysis therefore supports haploinsufficiency of the gene SHANK3 , which codes for a structural protein of the postsynaptic density, as a major causative factor in the neurological symptoms of 22q13 deletion syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmg.40.8.575

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 62 references

5 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

  1. 2001, Am J Hum Genet, 69, 583A
  2. 2000, Am J Hum Genet, 67, 376
  3. 1997, Am J Hum Genet, 60, 113
  4. 1994, Am J Hum Genet, 54, 464
  5. 1990, Am J Hum Genet, 47, A45
  6. 1996, Am J Hum Genet, 59, A117
  7. 1995, Am J Hum Genet, 57, A113
  8. 1991, Biotechniques, 11, 298
  9. 1984, Am J Ment Defic, 88, 380

Cited by

Sorted by citations

Items 301–377 of 377

Metadata

Authors
Wilson, H. L., Wong, A. C. C., Shaw, S. R., Tse, W.-Y., Stapleton, G. A., Phelan, M. C., Hu, S., Marshall, J., & McDermid, H. E.
Affiliations
  • University of Alberta (CA)
  • Greenville Children's Hospital (US)
  • Greenwood Genetic Center (US)
  • Children’s Hospital at Erlanger (US)
Corresponding author
McDermid, H E
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2003-08
Volume
40
Issue
8
Pages
575-584
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2172267891
Cited by
377
References
62
Citations by year
2026: 10 · 2025: 8 · 2024: 6 · 2023: 18 · 2022: 20 · 2021: 23 · 2020: 18 · 2019: 16 · 2018: 17 · 2017: 18 · 2016: 20 · 2015: 16 · 2014: 18 · 2013: 24 · 2012: 20
FWCI
5.28
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Medical Research Council Canada
  • Canadian Institutes of Health Research
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
Keywords
22q13 deletion syndrome, SHANK3, haploinsufficiency, paternal uniparental disomy, deletion size, intellectual disability, speech delay, postsynaptic density, parent of origin
MeSH terms
Base Sequence, Carrier Proteins, Developmental Disabilities, Chromosome Deletion, Chromosome Mapping, Chromosomes, Human, Pair 22, Female, Haplotypes, Humans, Infant, Language Development Disorders, Male, Intellectual Disability, Molecular Sequence Data, Nerve Tissue Proteins, Patents as Topic, Phenotype, Syndrome, Cytogenetic Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review